Encompass Health Corporation (NYSE:EHC) Faces Legal Scrutiny Amid Allegations
The Rosen Law Firm investigates potential securities claims against Encompass Health Corporation (NYSE:EHC) following allegations of misleading business information.Despite recent controversies, UBS upgraded Encompass Health's stock to a "Buy," raising the price target from $140 to $150.Encompass Health's current stock price stands at $123.23, with a market capitalization of approximately $12.41 billion.Encompass Health Corporation (NYSE:EHC) is under scrutiny as The Rosen Law Firm investigates potential se ...